Doctors and researchers are excited about new therapies derived from the study of the human genome that hold the promise of curing multiple forms of cancer using the patients’ own DNA to undo cancer cells.
The vast majority of new so-called precision medicine drugs coming on line in the next few years will strike at cancers at the molecular level.
Published in conjunction with 